Therefore, both CD8 and NK cells are required for an effective tumor regression indicating a synergistic action of CD8 T cells and NK cells (Fig. 7B, C green/blue) as major effector cells against MM. This evidence concerns the gene CD8A and Miyoshi myopathy.